| Bioactivity | Tasiamide B is a Cathepsin D inhibitor, which is a linear peptide found in the marine cyanobacteria Symploca sp.. Tasiamide B is proved as a good template for the development of aspartic proteases inhibitors. Tasiamide B is effective against skin cancer by strongly interacting with the target protein HSP90[1][2]. |
| CAS | 587014-85-5 |
| Formula | C50H74N8O12 |
| Molar Mass | 979.17 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li Z, et al. Design, synthesis, and bioactivities of tasiamide B derivatives as cathepsin D inhibitors. J Pept Sci. 2019 Apr;25(4):e3154. [2]. Vijayakumar S, et al. Tasiamide-B a new cyanobacterial compound for treating skin cancer[J]. Biomedicine & Preventive Nutrition, 2014, 4(3): 355-358. |
Tasiamide B
CAS: 587014-85-5 F: C50H74N8O12 W: 979.17
Tasiamide B is a Cathepsin D inhibitor, which is a linear peptide found in the marine cyanobacteria Symploca sp.. Tasiam
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.